Alphabet/Google Isn’t Evil but Genetically Modifying Mosquitos Might Be
By Mic Wright,
The Next Web
| 08. 25. 2015
Untitled Document
Blah blah don’t be evil blah blah blah. At some point, Google’s unofficial motto became like the message printed inside a stick of British seaside rock (see here for details, international readers). It’s a glib thing and chewing down on it too hard is apt to rot your teeth or perhaps your brain.
Google isn’t evil, anymore than any other corporation is evil. Watch the documentary, ‘The Corporation’ and you’ll hear a compelling argument that companies behave in a manner that is similar to sociopaths, but the individuals within Google/Alphabet genuinely do believe they are engaged in important, world-changing work – even the ones shovelling ads at your eyeballs.
But there’s a problem with people convinced they are engaged with a noble purpose. The old cliché that everyone is the hero of their own story and that no villain truly sees themselves as one is worth thinking about when it comes to boundary-pushing science.
In science fiction, we’re often confronted with inventors and experimenters who do something horrific because they thought they were acting in the interests of the greater...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...
By Staff, The Medicine Maker | 03.21.2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later...